Transurethral resection of the prostate (TURP) is considered as the gold standard for the management of bladder outlet obstruction due to benign prostatic hyperplasia (BPH). Long-term follow-up of the clinical effect of bipolar transurethral resection of the prostate (B-TURP) in saline for BPH is required. Objective: To compare, with long term follow-up, the efficacy and safety of B-TURP in the treatment of BPH with prostate gland volumes of <45 ml, >45 ml, and larger than 60 ml. Materials and Methods: From January 2006 to December 2016, 318 patients with a mean age of 69.45 ± 8.37 years and a median prostate volume of 42 cm 3 (56.51 -32.47) were treated with B-TURP by single urologist (SP) at the Division of Urology, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University. We retrospectively analyzed the perioperative status of patients' status follow-up for at least 6 months and up to 5 years. Post-void residual (PVR) and maximum flow rate (Qmax) were assessed preoperatively and postoperatively. Operative time, length of catheterization and hospitalization and complications were all reported. Results: The main indication for B-TURP was failure of medication (81.13%). Perioperative results showed no statistical significance among the groups in terms of catheterization days and the hospitalization length. During the follow-up, the improvement of postoperative parameters was compared with preoperative subscales, at different periods from baseline and after 24, 36, 48, and 60 months post treatment. PSA, Q max, PVR, and average flow rate were significantly different from pre-operation data (p < 0.005). Regarding TURP complications, significant differences were observed in relation to transient incontinence (5.87%), urinary tract infection (2.5%), urinary retention/catheterization (1.57%), contracture of bladder neck (4.4%), urethral strictures (4.09%), recurrence of BPH (2.83%), hypotonic bladder (0.6%) and erectile dysfunction (7.8%). No TUR syndrome or secondary hemorrhage was recorded in the study. Interestingly, complications in patients 
Introduction
Despite the rise of new minimally invasive technologies, transurethral resection of prostate (TURP) is the gold standard of surgical treatment for bothersome moderate severe lower urinary tract symptoms (LUTS) secondary to BPH [1] [2] [3]. The three main reasons for the continued popularity of TURP are a robust, simple technique; and, until now, unsurpassed efficacy; and, with regard to the risk-benefit ratio, a low morbidity [4] .
Monopolar (M-TURP) and bipolar (B-TURP) are safe, effective techniques and both are equally widely used in surgical treatment for BPH management [5] . Although M-TURP efficacy in prostate resection is established, potential perioperative complications and associated costs remain a concern [6] . In contrast, bipolar TURP is considered more efficacious and has a better clinical outcome in comparison with M-TURP [7] . In this study, B-TURP reported a significant reduction of related complications [3] [8] [9] . B-TURP coupled with 0.9% sodium chloride has minimal effects on serum sodium levels, compared with M-TURP [5] . Interestingly, Madduri et al. concluded that B-TURP is the new gold standard, since urologists prefer to operate on larger prostates using B-TURP, which definitely reduces the incidence of bleeding and hyponatremia [10] . However, many studies are conflicting regarding the merits of B-TURP over M-TURP.
[10] B-TURP is associated with high complication rates, especially secondary hemorrhage [11] [12] , and M-TURP should be used if surgeons want to save time [7] .
Moreover, present practice demonstrates the majority of a representative group of the Endourological Society members perform TURP in patients on ongoing oral anticoagulation (OA) [13] . To our knowledge, no report related to B-TURP in patients on ongoing oral anticoagulation (OA) in a long-term follow-up has been published. Therefore, in this study, we evaluated and compared the efficacy and safety of B-TURP in the treatment of BPH with prostate gland < 45 ml, > 45 ml and larger than 60 ml and with long term follow-up. We also evaluated the factors associated with complications especially secondary hemorrhage after B-TURP in patients on ongoing OA. Then, the Foley catheter was removed and the patients were discharged when voiding was satisfactory.
Material and Methods

From
We retrospectively analyzed the perioperative status of patients by follow-up for at least 6 months and up to 5 years. Postoperative parameters were evaluated and the patients were reassessed at 24, 36, 48 and 60-month follow-ups with the same examinations. PVR and Qmax were assessed preoperatively and postoperatively. Operative time, length of catheterization and hospitalization and complications were all reported. All data were entered in SPSS-17.0 software. A p-value less than 0.05 was considered as significant.
Results
At the beginning of the study, there were 318 patients. The mean age of the patients was 69.45 ± 8.37 years. Table 1 shows the baseline characteristics of patients who underwent B-TURP. Hypertension (57.86%) was the most common underlying disease of the patients. Indications for B-TURP included failure of medication (81.13%), acute urinary retention (11.95%) recurrence of UTI (3.77%), recurrence of hematuria (1.57%) and bladder stones (1.57%). B-TURP was performed in 27 patients (8.49%) on ongoing OA. The major anesthesia technique was spinal block (70.44%). Table 2 Postoperative comparisons of non-normally and normally distributed variables in three groups (prostate gland < 45 ml, > 45 ml and larger than 60 ml) are displayed in Table 3 and Table 4 Table 5 demonstrated the improvement of postoperative parameters at different periods compared with preoperative subscales in five subgroups at baseline and at 24, 36, 48, and 60 months after treatment. Median of PSA, Qmax, PVR and average flow rate before operation were 4.6 ng/ml, 11 ml/s, 60 ml and 5.6 ml/s, respectively. Median of PSA, Qmax, PVR and average flow rate at 60 months after the operation were 0.884 ng/ml, 18.8 ml/s, 25 ml and 9.85 ml/s, respectively.
Regarding TURP complications (Table 6 ), transient incontinence (5.87%), 
Discussion
Endoscopic management of BPH is based on resection, vaporization, or enucleation [15] . M-TURP was considered the gold standard for the management of bladder outlet obstruction due to BPH [10] . Later, B-TURP showed similar effect and safety in patients with BPH compared with those who underwent M-TURP. In BPH larger than 60 ml, a significant difference between the M-TURP and B-TURP groups was the greater decrease in serum sodium levels in the M-TURP group [16] . However many studies demonstrated that the issue of the benefit of B-TURP was, to some extent, controversial [7] [17]. Ahmad et al. reported that the duration of the resection and operating time was shorter in M-TURP than B-TURP and suggested urologists save time by using M-TURP [7] . Transurethral plasmakinetic enucleation and resection of the prostate (TUERP) is superior to B-TURP in the management of large volume BPH in terms of efficacy and safety, but needs to be validated in further prospective, randomized, controlled studies [18] . A steep operative learning curve may be the main obstacle to the widespread use of TUERP [19] . In the present study, a significant constant and gradual improvement over [20] . Most of the urethral strictures after B-TURP occurred at the bulbar urethra and may be linked to a slow resection rate [21] . In our study, the urethral stricture rate of 4.0% after B-TURP in this long term study of 60 months is comparable to previous series [21] .
In the contemporary B-TURP series, no TUR syndrome was found which confirmed that TUR syndrome is nowadays a clinical rarity [4] . Moreover, secondary hemorrhage after B-TURP and complications of patients on ongoing oral anticoagulation were not found in our study. We believe that many complications can be avoided by a proper resection technique. The main limitation of this study was that it was a retrospective review and small sample size.
The prevalence of erectile dysfunction in Thai males aged 40 -70 years old is 42.18% [22] . In our series with the mean age 69.45 years, the incidence of erectile dysfunction was 7.8%. It seems that B-TURP did not increase erectile dysfunction.
Conclusion
Our study confirms that B-TURP in patients' LUTS/BPH provides durable and comparable efficacy at 60 months follow up and is suitable for any prostate size.
